Skip to content

Effectiveness of outpatient rehabilitation treatment using the WelWalk for chronic stroke hemiplegia

Preliminary study on the effectiveness of outpatient rehabilitation treatment combining gait training using the Welwalk and exercise therapy for chronic stroke hemiplegia - PEORTGTWETCSH

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs042220066
Enrollment
12
Registered
2022-09-20
Start date
2022-09-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Rehabilitation treatment combining gait training using WelWalk and exercise therapy for 60 minutes a day, twice a week for 10 weeks.

Sponsors

Otaka Yohei
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who gave written consent to participate in this study from themselves or their proxy consents 2. Patients aged > 18 yo 3. Hemiplegic stroke patients eligible for outpatient treatment at the rehabilitation department of Fujita Health University Hospital 4. Patients more than 6 months after stroke onset 5. Patients who can walk independently or with supervision (regardless of the use of a walking aid) 6. Patients whose walking speed is 1.44 km/h or less 7. Patients weighing > 35 kg and 140 cm and < 190 cm

Exclusion criteria

Exclusion criteria: 1. Patients with a history of epileptic seizures within 3 months 2. Patients with symptomatic arrhythmias 3.Patients with pacemakers 4.Patients with uncontrolled hypertension (resting systolic BP > 180 mm Hg or diastolic BP > 120 mm Hg) 5.Patients with uncontrolled tachycardia (resting heart rate > 120 beats/min) 6.Patients with susceptible fractures of the legs or spine (such as severe osteoporosis) 7.Patients with ectopic ossification of the lower extremities leading to limited range of motion 8.Pregnant and possibly pregnant patients 9.Patients who have an infection and require isolation 10.When practicing wearing robot legs, patients who have difficulty wearing robot legs due to excessive or deformed lower limbs or pressure sores 11.Patients participating in intervention studies affecting other lower extremity/trunk movements and gait 12.Patients scheduled for antispasticity therapy with botulinum toxin preparations to the lower extremities during the study period 13.Patients with a change in walking speed greater than the minimum variable change (0.10 m/s) during the observation period before the start of the intervention 14.Other patients judged inappropriate by the attending physician, investigator, subinvestigator, or subinvestigator

Design outcomes

Primary

MeasureTime frame
Change in comfortable walking speed before and after intervention

Secondary

MeasureTime frame
Changes in the following indexes before and after intervention, and from before intervention to 4 weeks after intervention Comfortable gait speed, maximum gait speed Six-minute walking distance Spatio-temporal parameters for walking Parameters of gait calculated by three dimentional motion analysis system Timed up and go test Change in comfortable walking speed before and after each intervention Subjective assessment (Global rating of chance scales) after intervention and after 4 weeks of intervention.

Contacts

Public ContactSatoshi Hirano

Fujita Health University Hospital

sshirano@fujita-hu.ac.jp+81-562-93-2167

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026